By Kamal Choudhury Feb 25 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved Eton Pharmaceuticals' first-of-its-kind liquid therapy for a rare hormonal disorder, offering a more ...

Liquid alternative to desmopressin tablets allows for more precise dosing ...

The FDA has approved an oral liquid therapy for the treatment of central diabetes insipidus in people of all ages, according to a press release. Desmopressin acetate (Desmoda, Eton Pharmaceuticals) is ...

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...

By fine tuning the motion of molecules, scientists created an injectable therapy that encouraged the growth of neurites and ...

Food ‌and Drug ​Administration approved on Wednesday Eton ‌Pharmaceuticals' ⁠oral liquid therapy ⁠for a ​rare ​childhood ...

Desmoda oral solution is now FDA-approved for central diabetes insipidus, allowing clinicians to tailor dosing to individual water balance patterns.

By fine tuning the motion of molecules, scientists created an injectable therapy that encouraged the growth of neurites and neurons in damaged spinal organoids.

Northwestern University scientists have developed the most advanced organoid model for human spinal cord injury to date. In a new study, the research team used lab-grown human spinal cord ...

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...

Some of the most dangerous cancers are the types that are hard to detect. As a result, they are often caught too late to ...

Director Jeffrey Stein of IDEAYA Biosciences, Inc. NASDAQ:IDYA, recently purchased 50,000 shares of common stock. The transaction, which occurred on March 2, 2026, involved a total investment of $1.65 ...